Open Access

Downregulation of miR‑637 promotes proliferation and metastasis by targeting Smad3 in keloids

Corrigendum in: /10.3892/mmr.2023.13083

  • Authors:
    • Ye Zhang
    • Bingyu Guo
    • Qiang Hui
    • Wei Li
    • Peng Chang
    • Kai Tao
  • View Affiliations

  • Published online on: May 29, 2018     https://doi.org/10.3892/mmr.2018.9099
  • Pages: 1628-1636
  • Copyright: © Zhang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Keloids are a type of abnormal scar tissue. MicroRNAs (miRNAs) exhibit a pivotal role in the regulation of cell proliferation and metastasis of keloids. miRNA microarray revealed that miR‑637 was one of the most frequently altered miRNAs in keloids. Furthermore, up­regulation of miR‑637 inhibited cell proliferation and metastasis by targeting mothers against decapentaplegic homolog (Smad)3, one of the important proteins that affects the formation of keloids. Further studies demonstrated that miR‑637 regulated the proliferation and metastasis of human keloid fibroblast (HKF) cells by mediating the Smad3 signaling pathway. Overall, the present findings suggest that miR‑637 may be a promising therapeutic target in keloids.

Introduction

Keloid is a type of abnormal scar tissue, which is caused by excessive proliferation of fibroblasts, massive deposition of collagen and extracellular matrix, and deposition of core protein (1). However, keloid is difficult to completely cure, therefore it is necessary to find a more efficient strategy prevent and treat keloid.

The current study demonstrated that ~2/3 of the human protein encoding genome could be regulated by microRNAs (miRNAs). It has been reported that in keloid, miRNAs affect the proliferation, metastasis and differentiation of fibroblasts, and may also adjust the deposition of the extracellular matrix, which may affect the development of keloid (2).

The mothers against decapentaplegic homolog (Smad)3 mediated signaling pathway is closely associated with wound healing and scar formation (3). Previous studies have shown that Smad3 is highly expressed in pathological scar tissues, which induces the transition of fibroblasts to myofibroblasts (4). Inhibiting the expression of Smad3 can inhibit the formation of keloid (5).

In the current research, we aimed to investigate the differential expression of miRNAs in the keloid epidermis compared with that in the normal skin epidermis. For the selected, significantly lower expressed miR-637, the effects on the proliferation and metastasis of human keloid fibroblast cells were evaluated. The examinations were carried out to confirm the roles of miR-637 in the regulation of proliferation and metastasis of human keloid fibroblast cells. The involvement of miR-637 in the regulation of Smad3 signaling pathway in keloid fibroblast cells was additionally investigated.

Materials and methods

Tissue samples and cell lines

We enrolled keloid patients at the General Hospital of Shenyang Military Region (Shenyang, China) between January 2012 and January 2015. We obtained 30 paired samples of keloid and the excess normal tissue from the partial skin flap (control). All patients (14 female and 16 male, average age 31.25±7.39) had not received topical and systemic therapy for at least 2 months prior to undergoing a skin biopsy. We also retained three normal skin tissues from trauma patients as normal controls (normal). Written consent was gathered from all participants before the study was performed. The protocols were approved by the Ethics Committee of General Hospital of Shenyang Military Command.

Human keloid fibroblasts (HKF) were purchased from Bioleaf Corporation (Shanghai, China), and human embryonic skin fibroblasts obtained from Beijing Union Medical College cell bank. Cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% FBS (Hyclone; GE Healthcare Life Sciences, Logan, UT, USA), at 37°C in an environment containing 5% CO2.

RNA isolation

Tissues were stored in liquid nitrogen. Total RNA was extracted from tissues and cells using mirVana® miRNA isolation kit (Ambion; Thermo Fisher Scientific, Inc., Waltham, MA, USA) following the manufacturer's instructions. The quantity and quality of the extracted RNA were measured with a spectrophotometer (Thermo Fisher Scientific, Inc.). Finally, the sample was stored at −80°C.

MicroRNA microarray analysis

Agilent's Human miRNA Microarray Release 18.0 (Shanghai Biochip Co., Ltd., Shanghai, China) was used to detect the RNA from 3 keloids and 3 adjacent tissues. The slides were scanned by an Agilent Microarray Scanner with Feature Extraction Software 10.7, and raw data were normalized by Quantile algorithm, Gene Spring Software 11.0 (all by Agilent Technologies, Inc., Santa Clara, CA, USA). Differentially expressed microRNAs were identified by significance analysis of microarrays (SAM, http://www-stat.stanford.edu/tibs/SAM/index.html).

Quantitative polymerase chain reaction (qPCR)

qPCR was conducted with qPCR Universal Reagent and the MX3000P qPCR instrument following the protocols. U6 small nuclear RNA was used as an internal control. The expression of miR-637 was detected using Stem-Loop RT-PCR assay, as previously described (6,7). Primer sequences were synthesized as follows (Table I). All the reactions were carried out as described previously (8).

Table I.

Primers of RNAs.

Table I.

Primers of RNAs.

NameForward primer (5′-3′)Reverse primer (5′-3′)
miR-637 ACACTCACTGGGGGCTTT GCAGAGCCCGTTGAGAGTACA
miR-487 ACACTCAATCATACAGGGA AACTGGATGTTGAGAGTACAT
miR-154 ACACTCAATCATACACGGT AATAGGTCTTGAGAGTACAT
miR-582 ACACTCTAACTGGTTGAAC GGTTCAGTTTTGAGAGTACAT
miR-194 ACACTCCCAGTGGGGCTG CAGATAACAGTTGAGAGTACAT
miR-21 ACACTCCAACACCAGTCG ACAGCCCATTTGAGAGTACAT
miR-503 CACTCGGGGTATTGTTTCC CCTGGCAGCTTGAGAGTACAT
miR-550 ACACTCAGTGCCTGAGGGA CTCTTACTTGAGAGTACAT
U6 CTCGCTTCGGCAGCACA ACGCTTCACGAATTTGCGT
Smad3 GGGCTTTGAGGCTGTCTAC GTCCACGCTGGCATCTTCTG
Cyclin D1 CCAACCTCCTCAACGACC TGGCACAGAGGGCAACGAAG
MMP2 GATCTTGACCAGAATACCAT GGCTTGCGAGGGAAGAAGTT
GAPDH CATCCCTTCTCCCCACAC GTCCCAGGGCTTTGATTTG

[i] miRNA, microRNA; MMP, matrix metalloproteinase.

Western blot analyses

Cells and tissues were lysed and the protein was extracted using radioimmunoprecipitation assay buffer. Samples were resolved by 10% SDS-PAGE and transferred onto polyvinylidene difluoride PVDF membranes. Target proteins were probed with specific antibodies. Relative expression of relevant proteins were quantified and normalized to GAPDH. Antibodies used for western blotting were: anti-Smad3 (sc-101154, 1:500), anti-Cyclin D1 (sc-70899, 1:300), anti-matrix metallopeptidase (MMP)2 (sc-13594, 1:300), anti-GAPDH (sc-51631, 1:1,000) and horseradish peroxidase-conjugated anti-mouse (sc-2005, 1:5,000) secondary antibodies (Santa Cruz, USA).

Dual luciferase reporter assay

Dual luciferase activity assays were performed as previously described (9). The Smad3 3′-untranslated region (UTR) was PCR amplified and cloned into the pMIR-REPORT™ vector (Ambion; Thermo Fisher Scientific, Inc.). The primers were: Smad3-WT, F: 5′-AGGGCTTTGAGGCTGTCTACC-3′, R: 5′-GTCCACGCTGGCATCTTCTG-3′, Smad3-mut (the site of miR-637 binding was mutated), F: 5′-AAACCAGGCGGCTAAACAAGTG-3′, R: 5′-GCAACAGCAGCAGTGAAGGTG-3′. HKF cells were seeded and co-transfected with the above constructs and miR-637 mimic (Guangzhou Ribobio Co., Ltd, Guangzhou, China), miR-637 antisense (AS) (Guangzhou Ribobio Co., Ltd) or control (Guangzhou Ribobio Co., Ltd). Luciferase activity was determined with the dual luciferase reporter assay system after 36 h transfection; the luciferase activity was measured using the Dual Luciferase Reporter Assay System (Promega Corporation, Madison, WI, USA).

MTT assays

Cell proliferation activity was detected using an MTT assay (Solarbio, China). Cells were seeded at a density of 1×103 cells per well of 96-well plates, and transfected with miR-637 mimic, miR-637 inhibitor (Guangzhou Ribobio Co., Ltd) or negative control; then the cell proliferation was evaluated by MTT assay. A microplate reader (Bio-Rad Laboratories, Inc., Hercules, CA, USA) was used to measure the optical densities at a wavelength of 490 nm.

Transwell assay

A total of 12 h following transfection with miR-637 mimic, miR-637 inhibitor or negative control, 1×105 cells in serum-free media were seeded in transwell chambers with or without Matrigel coating, and then transwell assays were conducted. After 8 h cells were fixed by 4% paraformaldehyde, and stained with 0.4% trypan blue. Numbers of cells in different groups were determined using Image-Pro Plus 6.0 software (Nikon Corporation, Tokyo, Japan).

Construction of stable siRNA-expressing cell lines

To stably silence Smad3, cells were transfected with the pRS-si-Smad3 plasmid (Shanghai GeneChem Company) and were selected with G418 (400 µg/ml). After 3 weeks, stable cells were selected, cultured and amplified.

Statistical analysis

All data (showed as mean ± standard deviation) were analyzed with SPSS software, version 17.0 (SPSS Inc., Chicago, IL, USA). Statistical significance between two groups of data was evaluated by Student's t-test (two-tailed) and one-way analysis of variance following Fisher's Least Significant Difference post hoc test. Statistical significance was defined as P<0.05. All experiments were repeated three times.

Results

Differential expression profile of miRNAs in keloid tissues

The miRNA microarray revealed 15 downregulated (P<0.05) and 3 upregulated miRNAs (P<0.05) in keloid tissues compared with adjacent tissues (Table II). There were 8 miRNAs tat exhibited a fold change >x30. Among these miRNAs, we found that the change in miR-637 was the greatest. The expression levels of these miRNAs in keloid and adjacent tissues were detected by qPCR (Fig. 1A). The expression of miR-637 was verified to be significantly lower in keloid tissues. We compared the expression of miR-637 in keloid, normal tissues from keloid patients and normal skin tissues from trauma patients (Fig. 1B). It was found that miR-637 expression was low in keloid. It can be seen that miR-637 may play an important role in keloid.

Table II.

Differential miRNAs in keloids.

Table II.

Differential miRNAs in keloids.

miRNAP-valuesFold change (keloid/adjacent tissues)Trend
Hsa-miR-34a0.00127.265Down
Hsa-miR-4990.0312.905Down
Hsa-miR-5827.69×10-0554.608Down
Hsa-miR-1549.53×10-0665.257Down
Hsa-miR-1260.0234.167Down
Hsa-miR-1941.04×10-0450.137Down
Hsa-miR-1010.0116.072Down
Hsa-miR-980.00129.150Down
Hsa-miR-9400.00129.152Down
Hsa-miR-200c0.0097.689Down
Hsa-miR-1010.0069.871Down
Hsa-miR-6460.00313.509Down
Hsa-miR-1060.00411.097Down
Hsa-miR-4872.76×10-0531.825Down
Hsa-miR-6374.05×10-0669.303Down
Hsa-miR-216.61×10-0667.042Up
Hsa-miR-5030.00139.842Up
Hsa-miR-5509.75×10-0654.187Up

[i] miRNA, micro RNA.

The expression of Smad3 in keloid tissues

By using miRDB software, it was demonstrated that miR-637 targeted multiple proteins. Smad3 is not only an important regulatory protein in keloid, however also contains a binding site to miR-637. The expression of Smad3 in keloid and adjacent tissues was detected by western blotting and qPCR (Fig. 1C and D). The adjacent tissues were used as a control. Results showed that there was a higher expression of Smad3 in keloid tissues, compared with adjacent tissues (P<0.05).

Relationship between miR-637 and Smad3

We analyzed the correlation between the expression levels of miR-637 and Smad3 in keloid, and found that the expression in keloid was negatively correlated (Fig. 2A). Through use of the miRDB tool, we found that miR-637 was able to bind with the 3′-UTR of Smad3 (Fig. 2B). The Luciferase reporter assay showed that miR-637 reduced the expression of Smad3 at the transcriptional level (Fig. 2C). Results showed that when cells were co-transfected with Smad3 and miR-637, a decreased luciferase activity was observed (P<0.05), however, the cells co-transfected with Smad3 mut or miR-637 AS (Antisense) did not result in a significant variation. miR-637 mimic or miR-637 inhibitor were transfected into HKF cells, and then western blot and qPCR were conducted in order to detect the expression of Smad3 (Fig. 2D-G). Results showed that the expression of Smad3 could be downregulated by miR-637 (P<0.05).

miR-637 inhibits the proliferation of HKF cells by suppressing Cyclin D1

miR-637 mimic or inhibitor was transfected into HKF cells. The proliferation of HKF cells was measured by MTT assay. The result showed that miR-637 mimic significantly inhibited HKF cell proliferation and conversely, miR-637 inhibitor significantly promoted the proliferation of HKF cells (P<0.05) (Fig. 3A and B). Cyclin D1 is an important protein in the regulation of the cell cycle, and is one of the proteins involved in the Smad3 signaling pathway (10). We suspect that the inhibitory effect on HKF cell proliferation may be mediated by regulation of Cyclin D1. Western blotting and qPCR were used to detect the effect of miR-637 on Cyclin D1. The results showed that miR-637 significantly inhibited the expression of Cyclin D1 (P<0.05) (Fig. 3C-F).

miR-637 inhibits the metastasis of HKF cells by suppressing MMP2

Smad3 can affect the metastasis of cells in many ways, for example MMP2 is one of the downstream proteins of the Smad3 pathway (11). Transwell assays (with or without matrigel) were used to study whether miR-637 is involved in metastasis of HKF cells (Fig. 4A-D). The present study demonstrated that the migration and invasion of HKF cells was significantly inhibited by miR-637 (P<0.05). In addition, western blotting and qPCR showed that MMP2 was significantly downregulated by miR-637 (P<0.05) (Fig. 4E-H).

Smad3 is crucial to cell proliferation and metastasis of HKF cells

Smad3 small interfering (si)RNA significantly suppressed cell proliferation and metastasis ability of cells (P<0.05) (Fig. 5A and B). To explore the potential signaling pathways involved in the actions of miR-637 and Smad3 in HKF cells, Cyclin D1 and MMP2 expression levels were detected. Co-treatment with Smad3 siRNA and miR-637 inhibitor in cells significantly downregulated the level of Smad3 to a greater extent compared with miR-637 inhibitor alone (P<0.05), and the same trend was observed in the expression levels of Cyclin D1 and MMP2 (P<0.05) (Fig. 5C and D). The expression of tumor growth factor-β1 was downregulated by miR-637 inhibitor (P<0.05), however was not affected by Smad3 siRNA (Fig. 5C and D). These results suggested that miR-637 may regulate the proliferation and metastasis of HKF cells via Smad3 signaling pathway.

Discussion

A variety of miRNAs may be involved in the proliferation and migration of fibroblasts, and many miRNAs have been shown to regulate the formation of keloids (12). It has previously been demonstrated that p63 is affected by a high expression of miR-205 in the skin, and miR-205 influences cell differentiation of skin stem cells, and regulates the proliferation and apoptosis of fibroblasts (13). miR-222 stimulates the growth factor signaling pathway to promote cell cycle progression, thereby regulating the formation of keloids (14). It has also been revealed that miR-29b regulates collagen I in skin fibroblast cells, thereby affecting the formation of keloid (15). In a mouse model, abnormal expression of miR-31 and miR-21-5p has been revealed to be involved in the formation of keloid (16). The migration of fibroblasts may be affected by the regulation of miR-21 on MMPs, and this regulation is crucial in the formation of keloids (13,14,16,17). These findings demonstrated that miRNAs exhibit a key role in the healing of skin wounds, and predicted that they may play an important role in scar formation and skin remodeling. Researchers have reported that miR-637 inhibits the metastasis and growth of glioma cells by targeting the AKT pathway (18). miR-637 has also been shown to inhibit the formation of inflammation by regulating C-Reactive Protein (1921). However, the effect of miR-637 on keloid has not been studied yet.

Overexpression of Smad3 in keloid significantly upregulates pro-collagen gene expression, promotes deposition of extracellular matrix, proliferation and metastasis of fibroblasts (3,5,22). Therefore, Smad3 is one of the potential targets for keloid treatment (23).

Microarray analysis was used to screen abnormal expression of miRNAs in keloid. The results showed that miR-637, miR-487, miR-154, miR-582 and miR-194 were significantly downregulated in keloid, and the expression levels of miR-21, miR-503 and miR-550 were upregulated. Furthermore, we found that these miRNAs may play an important role in keloid. miR-637 was selected as the primary factor for investigation in the present study. It was proved that miR-637 directly affected the activity of Smad3 through the targeting of Smad3.

A keloid scar is an overgrowth of dense fibrous tissue that develops around a wound. These scars are raised scars that spread beyond the margins of the original wound to normal skin by invasion (24). The downregulation of miR-637 may be responsible for the enhanced capacity of keloid to proliferate and metastasise (25). miR-637 may affect the proliferation and migration of cells by inhibiting the expression of Cyclin D1 and MMP2. These two proteins can be regulated by Smad3 (26,27), leading to the hypothesis that regulation of miR-637 on proliferation and migration of fibroblasts is partly mediated by regulation of Smad3. The present study additionally demonstrated that miR-637 can influence the expression of TGF-β1 to some extent, as TGF-β1 has been proved to play an important role in keloid (28), and can regulate Smad3 activity (18,22,28). miR-637 has been shown to inhibit AKT pathway activity (18), and the inhibitory effect of miR-637 on Smad3 may be through its effects on TGF- β1 and targeting Smad3. This experiment has some limitations, and further experimentation is required in vivo to verify the results.

The results of the present study suggested that miR-637 participated in the regulation of keloid development by inhibition of Smad3, and may therefore act as a future potential target for keloid treatment.

Acknowledgements

Not applicable.

Funding

No funding was received.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Authors' contributions

YZ conceived of the present study and performed the molecular studies. BG also performed the molecular studies. QH participated in the design of the study and performed the statistical analysis. WL participated in its design and coordination of the study and helped to draft the manuscript. PC assisted in the conception of the study. KT contributed to analysis and interpretation of data.

Ethics approval and consent to participate

Written consent was gathered from all participants before the study was performed. The protocols were approved by the Ethics Committee of General Hospital of Shenyang Military Command (R201208).

Consent for publication

Patients have provided written informed consent for the publication of any associated data and accompanying images.

Competing interests

The authors declare that they have no competing interests.

References

1 

Yao X, Cui X, Wu X, Xu P, Zhu W, Chen X and Zhao T: Tumor suppressive role of miR-1224-5p in keloid proliferation, apoptosis and invasion via the TGF-β1/Smad3 signaling pathway. Biochem Biophys Res Commun. 495:713–720. 2018. View Article : Google Scholar : PubMed/NCBI

2 

Liu Y, Yang D, Xiao Z and Zhang M: miRNA expression profiles in keloid tissue and corresponding normal skin tissue. Aesthetic Plast Surg. 36:193–201. 2012. View Article : Google Scholar : PubMed/NCBI

3 

Jin SE, Kim CK and Kim YB: Cellular delivery of cationic lipid nanoparticle-based SMAD3 antisense oligonucleotides for the inhibition of collagen production in keloid fibroblasts. Eur J Pharm Biopharm. 82:19–26. 2012. View Article : Google Scholar : PubMed/NCBI

4 

Zhao B, Guan H, Liu JQ, Zheng Z, Zhou Q, Zhang J, Su LL and Hu DH: Hypoxia drives the transition of human dermal fibroblasts to a myofibroblast-like phenotype via the TGF-β1/Smad3 pathway. Int J Mol Med. 39:153–159. 2017. View Article : Google Scholar : PubMed/NCBI

5 

Phan TT, Lim IJ, Aalami O, Lorget F, Khoo A, Tan EK, Mukhopadhyay A and Longaker MT: Smad3 signalling plays an important role in keloid pathogenesis via epithelial-mesenchymal interactions. J Pathol. 207:232–242. 2005. View Article : Google Scholar : PubMed/NCBI

6 

Feng J, Wang K, Liu X, Chen S and Chen J: The quantification of tomato microRNAs response to viral infection by stem-loop real-time RT-PCR. Gene. 437:14–21. 2009. View Article : Google Scholar : PubMed/NCBI

7 

Chen C, Ridzon DA, Broomer AJ, Zhou Z, Lee DH, Nguyen JT, Barbisin M, Xu NL, Mahuvakar VR, Andersen MR, et al: Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 33:e1792005. View Article : Google Scholar : PubMed/NCBI

8 

Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e452001. View Article : Google Scholar : PubMed/NCBI

9 

Yang TS, Yang XH, Wang XD, Wang YL, Zhou B and Song ZS: MiR-214 regulate gastric cancer cell proliferation, migration and invasion by targeting PTEN. Cancer Cell Int. 13:682013. View Article : Google Scholar : PubMed/NCBI

10 

Zelivianski S, Cooley A, Kall R and Jeruss JS: Cyclin-dependent kinase 4-mediated phosphorylation inhibits Smad3 activity in cyclin D-overexpressing breast cancer cells. Mol Cancer Res. 8:1375–1387. 2010. View Article : Google Scholar : PubMed/NCBI

11 

Wang L, Clutter S, Benincosa J, Fortney J and Gibson LF: Activation of transforming growth factor-beta1/p38/Smad3 signaling in stromal cells requires reactive oxygen species-mediated MMP-2 activity during bone marrow damage. Stem Cells. 23:1122–1134. 2005. View Article : Google Scholar : PubMed/NCBI

12 

Zhang J, Xu D, Li N, Li Y, He Y, Hu X, Lyu L and He L: Downregulation of microRNA-31 inhibits proliferation and induces apoptosis by targeting HIF1AN in human keloid. Oncotarget. 8:74623–74634. 2017.PubMed/NCBI

13 

An G, Liang S, Sheng C, Liu Y and Yao W: Upregulation of microRNA-205 suppresses vascular endothelial growth factor expression-mediated PI3K/Akt signaling transduction in human keloid fibroblasts. Exp Biol Med (Maywood). 242:275–285. 2017. View Article : Google Scholar : PubMed/NCBI

14 

Li C, Bai Y, Liu H, Zuo X, Yao H, Xu Y and Cao M: Comparative study of microRNA profiling in keloid fibroblast and annotation of differential expressed microRNAs. Acta Biochim Biophys Sin (Shanghai). 45:692–699. 2013. View Article : Google Scholar : PubMed/NCBI

15 

Zhang GY, Wu LC, Liao T, Chen GC, Chen YH, Zhao YX, Chen SY, Wang AY, Lin K, Lin DM, et al: A novel regulatory function for miR-29a in keloid fibrogenesis. Clin Exp Dermatol. 41:341–345. 2016. View Article : Google Scholar : PubMed/NCBI

16 

Liu Y, Wang X, Yang D, Xiao Z and Chen X: MicroRNA-21 affects proliferation and apoptosis by regulating expression of PTEN in human keloid fibroblasts. Plast Reconstr Surg. 134:561e–573e. 2014. View Article : Google Scholar : PubMed/NCBI

17 

Wu ZY, Lu L, Liang J, Guo XR, Zhang PH and Luo SJ: Keloid microRNA expression analysis and the influence of miR-199a-5p on the proliferation of keloid fibroblasts. Genet Mol Res. 13:2727–2738. 2014. View Article : Google Scholar : PubMed/NCBI

18 

Que T, Song Y, Liu Z, Zheng S, Long H, Li Z, Liu Y, Wang G, Liu Y, Zhou J, et al: Decreased miRNA-637 is an unfavorable prognosis marker and promotes glioma cell growth, migration and invasion via direct targeting Akt1. Oncogene. 34:4952–4963. 2015. View Article : Google Scholar : PubMed/NCBI

19 

Yi W, Li D, Guo Y, Zhang Y, Huang B and Li X: Sevoflurane inhibits the migration and invasion of glioma cells by upregulating microRNA-637. Int J Mol Med. 38:1857–1863. 2016. View Article : Google Scholar : PubMed/NCBI

20 

Kim Y, Hooten Noren N, Dluzen DF, Martindale JL, Gorospe M and Evans MK: Posttranscriptional regulation of the inflammatory marker C-reactive protein by the RNA-binding protein HuR and MicroRNA 637. Mol Cell Biol. 35:4212–4221. 2015. View Article : Google Scholar : PubMed/NCBI

21 

Zhang JF, He ML, Fu WM, Wang H, Chen LZ, Zhu X, Chen Y, Xie D, Lai P, Chen G, et al: Primate-specific microRNA-637 inhibits tumorigenesis in hepatocellular carcinoma by disrupting signal transducer and activator of transcription 3 signaling. Hepatology. 54:2137–2148. 2011. View Article : Google Scholar : PubMed/NCBI

22 

Liang CJ, Yen YH, Hung LY, Wang SH, Pu CM, Chien HF, Tsai JS, Lee CW, Yen FL and Chen YL: Thalidomide inhibits fibronectin production in TGF-β1-treated normal and keloid fibroblasts via inhibition of the p38/Smad3 pathway. Biochem Pharmacol. 85:1594–1602. 2013. View Article : Google Scholar : PubMed/NCBI

23 

Wang Z, Gao Z, Shi Y, Sun Y, Lin Z, Jiang H, Hou T, Wang Q, Yuan X, Zhu X, et al: Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts. J Plast Reconstr Aesthet Surg. 60:1193–1199. 2007. View Article : Google Scholar : PubMed/NCBI

24 

Ma X, Chen J, Xu B, Long X, Qin H, Zhao RC and Wang X: Keloid-derived keratinocytes acquire a fibroblast-like appearance and an enhanced invasive capacity in a hypoxic microenvironment in vitro. Int J Mol Med. 35:1246–1256. 2015. View Article : Google Scholar : PubMed/NCBI

25 

Jiao H, Dong P, Yan L, Yang Z, Lv X, Li Q, Zong X, Fan J, Fu X, Liu X and Xiao R: TGF-β1 induces polypyrimidine tract-binding protein to alter fibroblasts proliferation and fibronectin deposition in keloid. Sci Rep. 6:380332016. View Article : Google Scholar : PubMed/NCBI

26 

Xia W, Lo CM, Poon RYC, Cheung TT, Chan ACY, Chen L, Yang S, Tsao GSW and Wang XQ: Smad inhibitor induces CSC differentiation for effective chemosensitization in cyclin D1- and TGF-β/Smad-regulated liver cancer stem cell-like cells. Oncotarget. 8:38811–38824. 2017.PubMed/NCBI

27 

Xu C, Lu G, Li Q, Zhang J, Huang Z and Gao X: Selenium modulates MMP2 expression through the TGFβ1/Smad signalling pathway in human umbilical vein endothelial cells and rabbits following lipid disturbance. J Trace Elem Med Biol. 42:59–67. 2017. View Article : Google Scholar : PubMed/NCBI

28 

Yao X, Cui X, Wu X, Xu P, Zhu W, Chen X and Zhao T: Tumor suppressive role of miR-1224-5p in keloid proliferation, apoptosis and invasion via the TGF-β1/Smad3 signaling pathway. Biochem Biophys Res Commun. 495:713–720. 2018. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

August-2018
Volume 18 Issue 2

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhang Y, Guo B, Hui Q, Li W, Chang P and Tao K: Downregulation of miR‑637 promotes proliferation and metastasis by targeting Smad3 in keloids Corrigendum in /10.3892/mmr.2023.13083. Mol Med Rep 18: 1628-1636, 2018
APA
Zhang, Y., Guo, B., Hui, Q., Li, W., Chang, P., & Tao, K. (2018). Downregulation of miR‑637 promotes proliferation and metastasis by targeting Smad3 in keloids Corrigendum in /10.3892/mmr.2023.13083. Molecular Medicine Reports, 18, 1628-1636. https://doi.org/10.3892/mmr.2018.9099
MLA
Zhang, Y., Guo, B., Hui, Q., Li, W., Chang, P., Tao, K."Downregulation of miR‑637 promotes proliferation and metastasis by targeting Smad3 in keloids Corrigendum in /10.3892/mmr.2023.13083". Molecular Medicine Reports 18.2 (2018): 1628-1636.
Chicago
Zhang, Y., Guo, B., Hui, Q., Li, W., Chang, P., Tao, K."Downregulation of miR‑637 promotes proliferation and metastasis by targeting Smad3 in keloids Corrigendum in /10.3892/mmr.2023.13083". Molecular Medicine Reports 18, no. 2 (2018): 1628-1636. https://doi.org/10.3892/mmr.2018.9099